NEW YORK (GenomeWeb News) – Single-cell technology firm Sphere Fluidics today announced the completion of a $2.5 million investment round.

24Haymarket led the round. Other investors included the Royal Society Enterprise Fund, Cambridge Enterprise, Providence Investment, the University of Cambridge Enterprise Fund, the London Business Angels Roundtable EIS Fund, and individual investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.